IYH, the iShares U.S. Healthcare ETF, enters the back half of September with an unusual lending-market tension — short interest has climbed sharply over the week while borrowing conditions have swung wildly between fully constrained and relatively loose.
The most striking development this week is the sudden spike in short positioning. Shares short rose roughly 48% over the past five trading sessions, jumping from around 376,000 to nearly 566,000. At just over 1% of free float, the absolute level remains low for a large ETF. But the speed of the move is notable — a near-doubling of borrowed shares in roughly one week points to deliberate hedging activity rather than noise.
The borrow market itself has been the real story. Availability swung from fully constrained — hitting 0% on multiple days through last week, a level matched only by the 52-week low of 0.36% — to a comparatively comfortable 176% on September 15. That whipsaw pattern suggests that borrowable supply has been episodically exhausted and then replenished, possibly as institutional holders move in and out of lending programs. Cost to borrow has followed a similar oscillating path, peaking near 5.4% earlier in the month before falling to 2.45% by Tuesday — its lowest reading in the recent run. The combination of rising short interest and volatile, recently easing borrow conditions paints a picture of active hedging demand that has periodically overwhelmed available supply.
Options positioning adds a mild defensive tilt. The put/call ratio on IYH moved up to 0.062 on September 15 — still extremely low in absolute terms, reflecting this ETF's call-heavy options structure — but the reading is running about 1.7 standard deviations above its 20-day average of 0.053. That gap, while modest, is the most elevated options positioning the fund has seen in recent weeks, consistent with a small uptick in protective buying. The 52-week PCR high of 0.72 underscores just how call-dominated this fund's options flow normally is, so any drift toward puts is worth flagging even when levels remain well below typical equity averages.
On the ownership side, the holder base reads as predominantly wealth-management platforms and wirehouse broker-dealers. UBS Asset Management topped the Q2 register at 5.7% of shares, adding roughly 52,000 shares. LPL Financial and Raymond James were also net buyers through June. On the other side, Wells Fargo trimmed about 132,000 shares — the largest reduction among top holders — and Goldman Sachs cut its position by 103,000. The overall pattern is one of rebalancing rather than conviction, consistent with the ETF's role as a tactical allocation vehicle rather than a single-stock bet.
The ORTEX short score eased to 44.7 on September 15, down from a range of 48-49 earlier in the week. That softening largely reflects the improvement in borrow availability and the dip in cost to borrow, even as the raw share count of shorts remains elevated. What's worth watching from here is whether the borrow market tightens again — availability has swung between near-zero and 176% six times in the past month, and each tightening episode has coincided with a spike in borrowing costs — and whether the healthcare sector faces any specific macro or regulatory catalyst that would explain the deliberate build in short positions.
See the live data behind this article on ORTEX.
Open IYH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
